These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36535979)

  • 1. In vitro characterization of immune modulating drug-eluting immunobeads towards transarterial embolization in cancer.
    Negussie AH; Mikhail AS; Owen JW; Hong N; Carlson CJ; Tang Y; Carrow KP; Mauda-Havakuk M; Lewis AL; Karanian JW; Pritchard WF; Wood BJ
    Sci Rep; 2022 Dec; 12(1):21886. PubMed ID: 36535979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization.
    Lewis AL; Gonzalez MV; Lloyd AW; Hall B; Tang Y; Willis SL; Leppard SW; Wolfenden LC; Palmer RR; Stratford PW
    J Vasc Interv Radiol; 2006 Feb; 17(2 Pt 1):335-42. PubMed ID: 16517780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin eluting beads - 1: effects of drug loading on bead characteristics and drug distribution.
    Lewis AL; Gonzalez MV; Leppard SW; Brown JE; Stratford PW; Phillips GJ; Lloyd AW
    J Mater Sci Mater Med; 2007 Sep; 18(9):1691-9. PubMed ID: 17483878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and characterization of image-able polyvinyl alcohol microspheres for image-guided chemoembolization.
    Negussie AH; Dreher MR; Johnson CG; Tang Y; Lewis AL; Storm G; Sharma KV; Wood BJ
    J Mater Sci Mater Med; 2015 Jun; 26(6):198. PubMed ID: 26105830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transarterial chemoembolization with DC Bead LUMI™ radiopaque beads for primary liver cancer treatment: preliminary experience.
    Aliberti C; Carandina R; Sarti D; Pizzirani E; Ramondo G; Cillo U; Guadagni S; Fiorentini G
    Future Oncol; 2017 Oct; 13(25):2243-2252. PubMed ID: 29063780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping Drug Dose Distribution on CT Images Following Transarterial Chemoembolization with Radiopaque Drug-Eluting Beads in a Rabbit Tumor Model.
    Mikhail AS; Pritchard WF; Negussie AH; Krishnasamy VP; Amchin DB; Thompson JG; Wakim PG; Woods D; Bakhutashvili I; Esparza-Trujillo JA; Karanian JW; Willis SL; Lewis AL; Levy EB; Wood BJ
    Radiology; 2018 Nov; 289(2):396-404. PubMed ID: 30106347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Composition-property relationships for radiopaque composite materials: pre-loaded drug-eluting beads for transarterial chemoembolization.
    Kilcup N; Tonkopi E; Abraham RJ; Boyd D; Kehoe S
    J Biomater Appl; 2015 Jul; 30(1):93-103. PubMed ID: 25690386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma.
    Nam HC; Jang B; Song MJ
    World J Gastroenterol; 2016 Oct; 22(40):8853-8861. PubMed ID: 27833376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Triple-Drug Transcatheter Arterial Chemoembolization (TACE) With Single-Drug TACE Using Doxorubicin-Eluting Beads: Long-Term Survival in 313 Patients.
    Gomes AS; Monteleone PA; Sayre JW; Finn RS; Sadeghi S; Tong MJ; Britten CD; Busuttil RW
    AJR Am J Roentgenol; 2017 Oct; 209(4):722-732. PubMed ID: 28705059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma.
    Song MJ; Chun HJ; Song DS; Kim HY; Yoo SH; Park CH; Bae SH; Choi JY; Chang UI; Yang JM; Lee HG; Yoon SK
    J Hepatol; 2012 Dec; 57(6):1244-50. PubMed ID: 22824821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of chemoembolization loadable beads: in vitro drug release and physical properties of DC bead and hepasphere loaded with doxorubicin and irinotecan.
    Jordan O; Denys A; De Baere T; Boulens N; Doelker E
    J Vasc Interv Radiol; 2010 Jul; 21(7):1084-90. PubMed ID: 20610183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a novel intrinsically radiopaque Drug-eluting Bead for image-guided therapy: DC Bead LUMI™.
    Ashrafi K; Tang Y; Britton H; Domenge O; Blino D; Bushby AJ; Shuturminska K; den Hartog M; Radaelli A; Negussie AH; Mikhail AS; Woods DL; Krishnasamy V; Levy EB; Wood BJ; Willis SL; Dreher MR; Lewis AL
    J Control Release; 2017 Mar; 250():36-47. PubMed ID: 28188808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety, Efficacy and Distribution of Doxorubicin Loaded Radiopaque Beads in Chemoembolization in Intermediate Stage Hepatocellular Carcinoma (HCC) with Correlation with Local Response.
    Malagari Κ; Kiakidis T; Moschouris H; Deutsch M; Tanteles S; Pantou E; Panagiotou I; Koskinas J; Glantzounis GK; Alexopoulou A; Filippiadis D; Brountzos E; Kelekis N
    Cardiovasc Intervent Radiol; 2023 Mar; 46(3):337-349. PubMed ID: 36653660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterisation of vandetanib-eluting radiopaque beads for locoregional treatment of hepatic malignancies.
    Hagan A; Phillips GJ; Macfarlane WM; Lloyd AW; Czuczman P; Lewis AL
    Eur J Pharm Sci; 2017 Apr; 101():22-30. PubMed ID: 28132823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of immune-modulating drugs for use in drug-eluting microsphere transarterial embolization.
    Mikhail AS; Mauda-Havakuk M; Negussie AH; Hong N; Hawken NM; Carlson CJ; Owen JW; Franco-Mahecha O; Wakim PG; Lewis AL; Pritchard WF; Karanian JW; Wood BJ
    Int J Pharm; 2022 Mar; 616():121466. PubMed ID: 35065205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin-loaded drug-eluting beads (DC Bead®) for use in transarterial chemoembolization: a stability assessment.
    Hecq JD; Lewis AL; Vanbeckbergen D; Athanosopoulos A; Galanti L; Jamart J; Czuczman P; Chung T
    J Oncol Pharm Pract; 2013 Mar; 19(1):65-74. PubMed ID: 22801955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro comparative study of multimodal imaging nano-assembled microspheres with two clinical drug-eluting beads loaded with doxorubicin.
    He Y; Xu T; Ding T; Gong Y; Zeng H; Xi Z; Ye Y; Song Z; Pan T; Zhang Z; Ma Q; Li L; Zhang Y; Shao G
    Drug Deliv; 2023 Dec; 30(1):2197177. PubMed ID: 37078789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cone-Beam Computed Tomography-Based Spatial Prediction of Drug Dose After Transarterial Chemoembolization Using Radiopaque Drug-Eluting Beads in Woodchuck Hepatocellular Carcinoma.
    Mikhail AS; Pritchard WF; Negussie AH; Inkiyad G; Long DJ; Mauda-Havakuk M; Wakim PG; van der Sterren W; Levy EB; Lewis AL; Karanian JW; Wood BJ
    Invest Radiol; 2022 Aug; 57(8):495-501. PubMed ID: 35239613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study.
    Lammer J; Malagari K; Vogl T; Pilleul F; Denys A; Watkinson A; Pitton M; Sergent G; Pfammatter T; Terraz S; Benhamou Y; Avajon Y; Gruenberger T; Pomoni M; Langenberger H; Schuchmann M; Dumortier J; Mueller C; Chevallier P; Lencioni R;
    Cardiovasc Intervent Radiol; 2010 Feb; 33(1):41-52. PubMed ID: 19908093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Chemoembolic Regimen on Immune Cell Recruitment and Immune Checkpoint Marker Expression following Transcatheter Arterial Chemoembolization in a VX2 Rabbit Liver Tumor Model.
    Berz AM; Santana JG; Iseke S; Gross M; Pekurovsky V; Laage Gaupp F; Savic LJ; Borde T; Gottwald LA; Boustani AM; Gebauer B; Lin M; Zhang X; Schlachter T; Madoff DC; Chapiro J
    J Vasc Interv Radiol; 2022 Jul; 33(7):764-774.e4. PubMed ID: 35346859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.